Back

“Belling the Cat” - Practical guide for cardiologists on Incorporating GLP-1RAs into comprehensive cardiovascular risk reduction

1 September 2019 (13:40 - 13:55)
Organised by:
Congress Presentation Part of: Multi-dimensional glucagon-like peptide-1 receptor agonists — Positioning their role in treatment of type 2 diabetes and cardiovascular disease Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

4 More presentations in this session

Presentation thumbnail
Chair’s Welcome
Professor L. Ryden (Stockholm, SE)
Video
Presentation thumbnail
Examining the link: type 2 diabetes and cardiovascular disease
Professor L. Ryden (Stockholm, SE)
Slides Video
Presentation thumbnail
Gazing into the future opportunities of glucagon-like peptide-1 receptor agonists in cardiovascular disease
Professor S. Verma (Toronto, CA)
Video
Presentation thumbnail
Connecting with the speakers - Questions and answers
Professor L. Ryden (Stockholm, SE) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)
Video

Access the full session

Session thumbnail
Multi-dimensional glucagon-like peptide-1 receptor agonists — Positioning their role in treatment of type 2 diabetes and cardiovascular disease

The Event

Event poster

ESC Congress 2019

1 September 2019 13:40 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources